Future Pak proposes acquisition of Vanda Pharmaceuticals for $7.25 to $7.75 per share in cash
Acquiring Company
Future Pak
Acquired Company
Vanda Pharmaceuticals
WixomWashingtonManufacturingBiotechnologyPharmaceuticalBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalBiopharmaDescription
Future Pak LLC has submitted a proposal to acquire all outstanding shares of common stock of Vanda Pharmaceuticals, Inc. for a cash consideration of $7.25 to $7.75 per share. The proposal implies a premium of 79.0% to 91.4% to Vanda's closing price as of April 16, 2024. Future Pak remains hopeful that the public disclosure of its interest will encourage shareholders to express their views on the proposal and on the Vanda Board’s responsibility to assess the highest and best price achievable for shareholders.
Quick answer
Future Pak is acquiring Vanda Pharmaceuticals, announced April 17, 2024. Future Pak is based in Wixom, Michigan, United States.
- How much did Future Pak pay for Vanda Pharmaceuticals?
- The deal value was not disclosed.
- What does Future Pak do?
- Future Pak LLC is a privately-held contract manufacturer and packager of pharmaceutical and nutraceutical products.
- Where are Future Pak and Vanda Pharmaceuticals based?
- Future Pak is based in Wixom, Michigan, United States. Vanda Pharmaceuticals is based in Washington, District Of Columbia, United States.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- Abbvie To Acquire Landos Biopharma, Further Strengthening Its Portfolio In Inflammatory And Autoimmune Diseases (March 25, 2024)
- Bristol Myers Squibb completes acquisition of Karuna Therapeutics, Inc. to strengthen its neuroscience portfolio (March 18, 2024)
- Nuvation Bio Inc. completes acquisition of AnHeart Therapeutics Ltd. to enhance its oncology pipeline (April 10, 2024)
- Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction (March 25, 2024)
- Harmony Biosciences acquires Epygenix Therapeutics, Inc. to expand rare epilepsy franchise (April 30, 2024)
Who to call at Future Pak, and when
When Future Pak changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Future Pak raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Future Pak, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Future Pak. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Future Pak makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Vanda Pharmaceuticals?
Vanda Pharmaceuticals was acquired by Future Pak, based in Wixom. The deal was reported on April 17, 2024. Future Pak LLC is a privately-held contract manufacturer and packager of pharmaceutical and nutraceutical products. Future Pak is privately held and operates in Manufacturing.
When did Future Pak acquire Vanda Pharmaceuticals?
Future Pak's acquisition of Vanda Pharmaceuticals was reported on April 17, 2024. Future Pak LLC has submitted a proposal to acquire all outstanding shares of common stock of Vanda Pharmaceuticals, Inc. for a cash consideration of $7.25 to $7.75 per share. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Vanda Pharmaceuticals do?
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. It is publicly traded (VNDA), operating in Biotechnology, and is based in Washington.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.